Aptevo Therapeutics shares owned by UBS Group

Quarter-by-quarter ownership of Aptevo Therapeutics shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Aptevo Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aptevo Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csv

Download as Excel

Quarterly reported holdings in Aptevo Therapeutics by UBS Group

Quarter filed	Position value	Share count	Share price at filing
2025-12-31	$1.6k	170	9.40

Disclaimers: stockzoa.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on stockzoa.com represent a recommendation to purchase or sell a stock. The information on this site is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall stockzoa.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content available on stockzoa.com, or relating to the use of, or inability to use, stockzoa.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

Fund Directory: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X-Z

Aptevo Therapeutics shares owned by UBS Group

Historical chart of UBS Group investment in Aptevo Therapeutics

Tip: Access up to 7 years of quarterly data

Quarterly reported holdings in Aptevo Therapeutics by UBS Group

Top funds holding Aptevo Therapeutics